Cargando…
Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro
BACKGROUND: A nanoscale injectable in situ-forming hydrogel drug delivery system was developed in this study. The system was based on a self-assembling peptide RADA16 solution, which can spontaneously form a hydrogel rapidly under physiological conditions. We used the RADA16 hydrogel for the control...
Autores principales: | Liu, Jingping, Zhang, Lanlan, Yang, Zehong, Zhao, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215155/ https://www.ncbi.nlm.nih.gov/pubmed/22114478 http://dx.doi.org/10.2147/IJN.S24038 |
Ejemplares similares
-
Antitumor Effects of Self-Assembling Peptide-Emodin in situ Hydrogels in vitro and in vivo
por: Wei, Weipeng, et al.
Publicado: (2021) -
Study of the interaction between self-assembling peptide and mangiferin and in vitro release of mangiferin from in situ hydrogel
por: Meng, Cui, et al.
Publicado: (2019) -
Experimental anti-tumor effect of emodin in suspension – in situ hydrogels formed with self-assembling peptide
por: Wei, Weipeng, et al.
Publicado: (2021) -
Sustained release of hepatocyte growth factor by cationic self-assembling peptide/heparin hybrid hydrogel improves β-cell survival and function through modulating inflammatory response
por: Liu, Shuyun, et al.
Publicado: (2016) -
Designer Self‐Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer
por: Yang, Zehong, et al.
Publicado: (2020)